GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (TSXV:NXG) » Definitions » Debt-to-Revenue

NexgenRx (TSXV:NXG) Debt-to-Revenue : 0.03 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is NexgenRx Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

NexgenRx's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.06 Mil. NexgenRx's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.40 Mil. NexgenRx's annualized Revenue for the quarter that ended in Dec. 2023 was C$14.30 Mil. NexgenRx's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.03.


NexgenRx Debt-to-Revenue Historical Data

The historical data trend for NexgenRx's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NexgenRx Debt-to-Revenue Chart

NexgenRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.13 0.03 0.03 0.03

NexgenRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.03

Competitive Comparison of NexgenRx's Debt-to-Revenue

For the Healthcare Plans subindustry, NexgenRx's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NexgenRx's Debt-to-Revenue Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NexgenRx's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where NexgenRx's Debt-to-Revenue falls into.



NexgenRx Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

NexgenRx's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.059 + 0.402) / 13.846
=0.03

NexgenRx's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.059 + 0.402) / 14.296
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


NexgenRx Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of NexgenRx's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NexgenRx (TSXV:NXG) Business Description

Traded in Other Exchanges
Address
191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.
Executives
Paul Crossett 10% Security Holder